leisure time -WSS

leisure time

author：entertainment 2025-09-07 11:17:16 - browse：1446

David Liu and Jonathan Wosen on the STAT Summit stage. — David Liu (left) with reporter Jonathan Wosen at the 2022 STAT Summit. STAT

David Liu, the Broad Institute biochemist behind two powerful forms of genome editing, is launching a company focused on delivering gene-editing machinery to precise cells and tissues in the body, STAT has learned.

The company, known as Nvelop, already raised a $100 million seed round last year, according to PitchBook. It is being run by Jeff Walsh, a former top executive at Bluebird Bio, and it recently recruited Bluebird’s head of research, Melissa Bonner, according to two people with knowledge of the situation. Bluebird had not previously disclosed Bonner’s departure.

Nvelop is the latest entry in a race among top labs and deep-pocketed investors to solve a delivery problem that has stunted efforts to turn CRISPR and other genetic tools into disease-altering medicines. The goal is to develop a cargo system precise enough to deliver CRISPR or other machinery to cells of a researchers’ choosing, particularly tissues that have been hard to reach with previous approaches, like neurons, muscle, and blood stem cells.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Prescription digital therapeutics are key to pharma’s future

focus

WSS

AstraZeneca lung cancer study comes in below expectations

Skip the lead apron during X

Hubble vs. James Webb telescope images: See the difference

Adam's Take: Intra

What Kate Middleton's cancer revelation might teach the world

Readout LOUD podcast, live from the STAT Breakthrough Summit East

hotspot

leisure time

leisure time

Affirmative action in medical school literally saved lives

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

AstraZeneca lung cancer study comes in below expectations

How to save PrEP access — and even expand it

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

Continuity nursing helped my family in our darkest PICU moments

Steward Health Care expansion into Malta flopped

Malaria cases in Florida and Texas: Here’s what you need to know

Asbestos ban is immediate, but health effects will linger for decades

focus

Medicare Advantage insurers pressure Biden for bigger payments

Asbestos ban is immediate, but health effects will linger for decades

Asbestos ban is immediate, but health effects will linger for decades

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Canadians with cystic fibrosis outlive Americans by a decade

Use doctors trained outside the U.S. to ease the physician shortage

leisure time

focus

knowledge

hotspot